Jump to content

Camellia Tsang: Difference between revisions

From Soutar36
No edit summary
No edit summary
Line 25: Line 25:
  | data1 = does not display (same number as a header)
  | data1 = does not display (same number as a header)
  | label2 = In Office
  | label2 = In Office
  | data2 =  
  | data2 = 16 May 2052 - Present
  | label3 = Chairman
  | label3 = Chairman
  | data3 =  
  | data3 = TBD
  | label4 = CEO
  | label4 = CEO
  | data4 =  
  | data4 = TBD
  | label5 = Preceded by
  | label5 = Preceded by
  | data5 = TBD
  | data5 = TBD
Line 43: Line 43:
  | data10 = does not display (same number as a header)
  | data10 = does not display (same number as a header)
  | label11 = In Office
  | label11 = In Office
  | data11 = TBD
  | data11 = 8 Jul 2051 - Present
  | label12 = CEO
  | label12 = CEO
  | data12 = TBD
  | data12 = TBD
Line 74: Line 74:
  | header37 =
  | header37 =
  | label37 = Born
  | label37 = Born
  | data37 = 3 November 2021 (age 34) <br> Hong Kong SAR<br>China
  | data37 = 3 November 2020 (age 35) <br> Hong Kong SAR<br>China
  | label39 = Nationality
  | label39 = Nationality
  | data39 = [[File:USA Flag (Better).png|16px]] United States
  | data39 = [[File:USA Flag (Better).png|16px]] United States
Line 101: Line 101:
  |belowstyle = background: #ddf;
  |belowstyle = background: #ddf;
  |below      =  
  |below      =  
}}'''Camellia Tsang Yam-Yu''' (Traditional Chinese: 曾衽羽, ''Jyutping: cang1 jam6 jyu5'', ''Pinyin: Zeng Renyu'') (born 6 June 1999) is an American entrepreneur, scientist and philanthropist who has been serving since 5 January 2030 as Chief Executive Officer of Nimbus Therapeutics Inc., the company she co-founded alongside TBD and TBD. Previously, she worked at Impossible Foods, Inc. from 2026 to 2030, rising to become the director of the company's global research center in April 2029. She has also been a trustee of the Kao Foundation since 16 February 2032, and is known for frequently championing environmental and social causes.
}}'''Camellia Tsang Yam-Yu''' (Traditional Chinese: 曾衽羽, ''Jyutping: cang1 jam6 jyu5'', ''Pinyin: Zeng Renyu'') (born 6 June 1999) is an Chinese-American entrepreneur and business executive who has
 
who has been serving since 5 January 2030 as Chief Executive Officer of Nimbus Therapeutics Inc., the company she co-founded alongside TBD and TBD. Previously, she worked at Impossible Foods, Inc. from 2026 to 2030, rising to become the director of the company's global research center in April 2029. She has also been a trustee of the Kao Foundation since 16 February 2032, and is known for frequently championing environmental and social causes.

Revision as of 16:04, 17 January 2026

Camellia Tsang
曾衽羽
Business Executive
Camellia Tsang in 2055
Executive VP, Nanyang Commercial Bank
In Office16 May 2052 - Present
ChairmanTBD
CEOTBD
Preceded byTBD
Succeeded byTBD
Salary$2,210,300 (2054)
Chair, Aphrodite Holdings LLC
In Office8 Jul 2051 - Present
CEOTBD
Preceded byTBD
Succeeded byTBD
Consort of the House of Juno
In Office2041 - 2046
PatronJulian Kao
Chief of StaffTBD
PrefectTBD
Preceded byTBD
Succeeded byTBD
Personal Information
Born3 November 2020 (age 35)
Hong Kong SAR
China
Nationality United States
Height168 cm (5'6")
Breasts32D
HairBlack
EyesBlack
Dress Size4
EducationStanford University (BA)
SpouseJulian Kao (m. 2046)
FamilyTBD (father)
Jessica Stroud (sister-wife)
Hannah Hazeldon (sister-wife)

Camellia Tsang Yam-Yu (Traditional Chinese: 曾衽羽, Jyutping: cang1 jam6 jyu5, Pinyin: Zeng Renyu) (born 6 June 1999) is an Chinese-American entrepreneur and business executive who has

who has been serving since 5 January 2030 as Chief Executive Officer of Nimbus Therapeutics Inc., the company she co-founded alongside TBD and TBD. Previously, she worked at Impossible Foods, Inc. from 2026 to 2030, rising to become the director of the company's global research center in April 2029. She has also been a trustee of the Kao Foundation since 16 February 2032, and is known for frequently championing environmental and social causes.